Melatonin and the Regulation of Sleep and Circadian Rhythms

Principles and Practice of Sleep Medicine: Fifth Edition

Volumn , Issue , 2010, Pages 420-430

  Guardiola Lemaître, Béatrice ^a   Quera Salva, Maria Antonia ^b  

^a ADIR   (France)

^b UNIVERSITÉ PARIS OUEST NANTERRE LA DÉFENSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885162074     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6645-3.00036-0     Document Type: Chapter

References (153)

1. Reinberg A, Halberg F Circadian chronopharmacology. Annu Rev Pharmacol 1971, 11:455-492.
2. Reinberg AE Concepts in chronopharmacology. Annu Rev Pharmacol Toxicol 1992, 32:51-66.
3. Reinberg A, Lagoguey M, Cesselin F, et al. Circadian and circannual rhythms in plasma hormones and other variables of five healthy young human males. Acta Endocrinol (Copenh) 1978, 88(3):417-427.
4. Smolensky MH, Hermida RC, Haus E, et al. Biological rhythms, medication safety, and women's health. J Womens Health (Larchmt) 2005, 14(1):38-46.
5. Reinberg A, Koulbanis C, Soudant E, et al. Day-night differences in effects of cosmetic treatments on facial skin. Effects on facial skin appearance. Chronobiol Int 1990, 7(1):69-79.
6. Le Fur I, Reinberg A, Lopez S, et al. Analysis of circadian and ultradian rhythms of skin surface properties of face and forearm of healthy women. J Invest Dermatol 2001, 117(3):718-724.
7. Ruiter M, Buijs RM, Kalsbeek A Hormones and the autonomic nervous system are involved in suprachiasmatic nucleus modulation of glucose homeostasis. Curr Diabetes Rev 2006, 2(2):213-226.
8. Czeisler CA, Duffy JF, Shanahan TL, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999, 284(5423):2177-2181.
9. Buijs RM, Wortel J, Hou YX Colocalization of gamma-aminobutyric acid with vasopressin, vasoactive intestinal peptide, and somatostatin in the rat suprachiasmatic nucleus. J Comp Neurol 1995, 358(3):343-352.
10. Mirmiran M, Kok JH Circadian rhythms in early human development. Early Hum Dev 1991, 26(2):121-128.
11. Lerner AB, Case JD, Takahashi Y, et al. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 1958, 80:2587.
12. Cassone VM Effects of melatonin on vertebrate circadian systems. Trends Neurosci 1990, 13(11):457-464.
13. Klein DC The 2004 Aschoff/Pittendrigh lecture: Theory of the origin of the pineal gland-a tale of conflict and resolution. J Biol Rhythms 2004, 19(4):264-279.
14. Arendt J Melatonin: characteristics, concerns, and prospects. J Biol Rhythms 2005, 20(4):291-303.
15. Goldman BD, Darrow JM The pineal gland and mammalian photoperiodism. Neuroendocrinology 1983, 37(5):386-396.
16. 2 melatonin receptors in mammals. Endocrine 2005, 27(2):101-110.
17. Masson-Pevet M, George D, Kalsbeek A, et al. An attempt to correlate brain areas containing melatonin-binding sites with rhythmic functions: a study in five hibernator species. Cell Tissue Res 1994, 278(1):97-106.
18. Stankov B, Capsoni S, Lucini V, et al. Autoradiographic localization of putative melatonin receptors in the brains of two Old World primates: Cercopithecus aethiops and Papio ursinus. Neuroscience 1993, 52(2):459-468.
19. Berson D, Dunn F, Takao M Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002, 295(5557):955-957.
20. Alarma-Estrany P, Pintor J Melatonin receptors in the eye: location, second messengers and role in ocular physiology. Pharmacol Ther 2007, 113(3):507-522.
21. Launay JM, Lamaitre BJ, Husson HP, et al. Melatonin synthesis by rabbit platelets. Life Sci 1982, 31(14):1487-1494.
22. Viswanathan M, Laitinen JT, Saavedra JM Vascular melatonin receptors. Biol Signals 1993, 2(4):221-227.
23. Kemp D, Ubeda M, Habener J Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol 2002, 191(2):157-166.
24. Barrett P, Schuster C, Mercer J, Morgan PJ Sensitization: a mechanism for melatonin action in the pars tuberalis. J Neuroendocrinol 2003, 15(4):415-421.
25. O'neill J, Maywood ES, Chesham JE, et al. cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 2008, 320:949-953.
26. 3 binding site on the NRH:quinone oxidoreductase 2 enzyme. Biochem Pharmacol 2005, 71(1-2):74-88.
27. 3 as the quinone reductase 2. J Biol Chem 2000, 275(40):31311-31317.
28. Tan DX, Manchester LC, Sainz RM, et al. Physiological ischemia/reperfusion phenomena and their relation to endogenous melatonin production: a hypothesis. Endocrine 2005, 27(2):149-158.
29. Wiesenberg I, Missbach M, Kahlen JP, et al. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res 1995, 23(3):327-333.
30. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 1994, 269(46):28531-28534.
31. Arendt J Importance and relevance of melatonin to human biological rhythms. J Neuroendocrinol 2003, 15(4):427-431.
32. Wehr TA, Schwartz PJ, Turner EH, et al. Bimodal patterns of human melatonin secretion consistent with a two-oscillator model of regulation. Neurosci Lett 1995, 194(1-2):105-108.
33. Arendt J Melatonin. Clin Endocrinol (Oxf) 1988, 29(2):205-229.
34. Bojkowski CJ, Arendt J Annual changes in 6-sulphatoxymelatonin excretion in man. Acta Endocrinol (Copenh) 1988, 117(4):470-476.
35. Bartke A, Steger R Seasonal changes in the function of the hypothalamic pituitary testicular axis in the Syrian hamster. Proc Soc Exp Biol Med 1992, 199(139):148.
36. Pevet P The role of the pineal gland in the photoperiodic control of reproduction in different hamster species. Reprod Nutr Dev 1988, 28(2B):443-458.
37. Bartness TJ, Wade A Photoperiodic control of body weight and energy metabolism in Syrian hamsters (Mesocricetus auratus): role of the pineal gland, melatonin, gonads and diet. Endocrinology 1984, 114:492-498.
38. LeMaitre BJ, Bouillie J, Hartmann L Variation of urinary melatonin excretion in humans during the first 30 years of life. Clin Chim Acta 1981, 110(1):77-82.
39. Hartmann L, Roger M, LeMaitre BJ, et al. Plasma and urinary melatonin in male infants during the first 12 months of life. Clin Chim Acta 1982, 121(1):37-42.
40. Czeisler CA, Dumont M, Duffy JF, et al. Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet 1992, 340(8825):933-936.
41. Guardiola-Lemaitre B Development of melatonin analogs. Advances in pineal research 1991, 351-363. John Libbey, London. A. Foldes, R.J. Reiter (Eds.).
42. Sack RL, Auckley D, Auger R, et al. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep 2007, 30(11):1484-1501.
43. Bartness TJ, Powers J, Hastings MH, et al. The time infusion paradigm for melatonin delivery: what has it taught us about the melatonin signal, its reception nd the photoperiodic control of seasonal responses. J Pineal Res 1993, 15:161-190.
44. Redman J, Armstrong S, Ng KT Free-running activity rhythms in the rat: entrainment by melatonin. Science 1983, 219(4588):1089-1091.
45. Redman JR, Armstrong SM Reentrainment of rat circadian activity rhythms: effects of melatonin. J Pineal Res 1988, 5(2):203-215.
46. Cagnacci A, Soldani R, Laughlin G, Yen S Modification of circadian body temperature rhythm during the luteal menstrual phase: role of melatonin. J Appl Physiol 1996, 80(1):25-29.
47. Zisapel N Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. CNS Drugs 2001, 15(4):311-328.
48. Sack RL, Auckley D, Auger R, et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. Sleep 2007, 30(11):1460-1483.
49. Turek FW, Gillette MU Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. Sleep Med 2004, 5(6):523-532.
50. Morgenthaler T, Lee-Chiong T, Alessi C, et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. Sleep 2007, 30(11):1445-1459.
51. Arendt J, van Someren EJ, Appleton R, et al. Clinical update: melatonin and sleep disorders. Clin Med 2008, 8(4):381-383.
52. Rajaratnam SMW, Middleton B, Stone BM, Arendt J Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans. J Physiol 2004, 561(1):339-351.
53. Krauchi K, Cajochen C, Mori D, et al. Early evening melatonin and S-20098 advance circadian phase and nocturnal regulation of core body temperature. Am J Physiol 1997, 272(4 Pt 2):R1178-R1188.
54. Benloucif S, Burgess H, Klerman E, et al. Measuring melatonin in humans. J Clin Sleep Med 2008, 4(1):66-69.
55. Lewy AJ, Sack RL The dim light melatonin onset as a marker for circadian phase position. Chronobiol Int 1989, 6(1):93-102.
56. Zhdanova IV, Wurtman R, Lynch H Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995, 57(5):552-558.
57. James SP, Sack D, Rosenthal N, Mendelson W Melatonin administration in insomnia. Neuropsychopharmacology 1990, 3(1):19-23.
58. MacFarlane J, Cleghorn J, Brown G, Streiner D The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study. Biol Psychiatry 1991, 30(4):371-376.
59. Boivin DB, Tremblay GM, James FO Working on atypical schedules. Sleep Med 2007, 8(6):578-589.
60. Santhi N, Aeschbach D, Horowitz T, Czeisler CA The impact of sleep timing and bright light exposure on attentional impairment during the night work. J Biol Rhythms 2008, 23(4):341-352.
61. Schwartz JR, Roth T Shift work sleep disorder: burden of illness and approaches to management. Drugs 2006, 66(18):2357-2370.
62. Smolensky MH, Reinberg A Clinical chronobiology: relevance and applications to the practice of occupational medicine. Occup Med 1990, 5(2):239-272.
63. Ashkenazi IE, Reinberg AE, Motohashi Y Interindividual differences in the flexibility of human temporal organization: pertinence to jet lag and shiftwork. Chronobiol Int 1997, 14(2):99-113.
64. Costa G, Akerstedt T, Nachreiner F, et al. Flexible working hours, health, and well-being in Europe: some considerations from a SALTSA project. Chronobiol Int 2004, 21(6):831-844.
65. Basner RC Shift-work sleep disorder-the glass is more than half empty. N Engl J Med 2005, 353(5):519-521.
66. Drake CL, Roehrs T, Richardson G, et al. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep 2004, 27(8):1453-1462.
67. Mitler MM, Miller JC, Lipsitz JJ, et al. The sleep of long-haul truck drivers. N Engl J Med 1997, 337(11):755-761.
68. Kilpatrick K, Lavoie-Tremblay M Shiftwork: what health care managers need to know. Health Care Manag (Frederick) 2006, 25(2):160-166.
69. Leproult R, Colecchia EF, Berardi AM, et al. Individual differences in subjective and objective alertness during sleep deprivation are stable and unrelated. Am J Physiol Regul Integr Comp Physiol 2003, 284(2):R280-R290.
70. Quera-Salva MA, Defrance R, Claustrat B, et al. Rapid shift in sleep time and acrophase of melatonin secretion in short shift work schedule. Sleep 1996, 19(7):539-543.
71. Quera-Salva MA, Guilleminault C, Claustrat B, et al. Rapid shift in peak melatonin secretion associated with improved performance in short shift work schedule. Sleep 1997, 20(12):1145-1150.
72. Reinberg A, Andlauer P, De Prins J, et al. Desynchronization of the oral temperature circadian rhythm and intolerance to shift work. Nature 1984, 308(5956):272-274.
73. Archer SN, Robilliard DL, Skene DJ, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003, 26(4):413-415.
74. Goulet G, Mongrain V, Desrosiers C, et al. Daily light exposure in morning-type and evening-type individuals. J Biol Rhythms 2007, 22(2):151-158.
75. Crowley S, Lee C, Tseng C, et al. Combinations of bright light, schedultd dark, sunglasses, and melatonin to facilitate circadian entrainment to night shift work. J Biol Rhythms 2003, 18(6):513-523.
76. Santhi N, Duffy JF, Horowitz T, Czeisler CA Scheduling of sleep/darkness affects the circadian phase of night shift workers. Neurosci Lett 2005, 384(3):316-320.
77. Lee C, Smith M, Eastman CI A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure. Chronobiol Int 2006, 23(4):859-875.
78. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 2001, 93(20):1563-1568.
79. Davis S, Mirick DK, Stevens RG Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001, 93(20):1557-1562.
80. Hansen J Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001, 12(1):74-77.
81. Pukkala E, Auvinen A, Wahlberg G Incidence of cancer among Finnish airline cabin attendants, 1967-92. BMJ 1995, 311(7006):649-652.
82. Tynes T, Hannevik M, Andersen A, et al. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996, 7(2):197-204.
83. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 2001, 12(2):95-101.
84. Vijayalaxmi Thomas CR, Reiter RJ, Herman TS Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002, 20(10):2575-2601.
85. Subramanian A, Kothari L Melatonin, a suppressor of spontaneous murine mammary tumors. J Pineal Res 1991, 10(3):136-140.
86. Schernhammer ES, Kroenke CH, Dowsett M, et al. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J Pineal Res 2006, 40(2):116-124.
87. Spiegel K, Leproult R, L'Hermite-Baleriaux M, et al. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 2004, 89(11):5762-5771.
88. Spiegel K, Tasali E, Penev P, Van Cauter E Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141(11):846-850.
89. Di Lorenzo L, De Pergola G, Zocchetti C, et al. Effect of shift work on body mass index: results of a study performed in 319 glucose-tolerant men working in a Southern Italian industry. Int J Obes Relat Metab Disord 2003, 27(11):1353-1358.
90. Karlsson B, Knutsson A, Lindahl B Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 2001, 58(11):747-752.
91. Knutson KL, Spiegel K, Penev P, Van Cauter E The metabolic consequences of sleep deprivation. Sleep Med Rev 2007, 11(3):163-178.
92. Van Cauter E, Holmback U, Knutson K, et al. Impact of sleep and sleep loss on neuroendocrine and metabolic function. Horm Res 2007, 67(Suppl 1):2-9.
93. Spiegel K, Leproult R, Van Cauter E Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354(9188):1435-1439.
94. Nagaya T, Yoshida H, Takahashi H, Kawai M Markers of insulin resistance in day and shift workers aged 30-59 years. Int Arch Occup Environ Health 2002, 75(8):562-568.
95. Spiegel K, Knutson K, Leproult R, et al. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005, 99(5):2008-2019.
96. Wolk R, Somers VK Sleep and the metabolic syndrome. Exp Physiol 2007, 92(1):67-78.
97. Knutson KL, Ryden AM, Mander BA, Van Cauter E Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006, 166(16):1768-1774.
98. Kroenke CH, Spiegelman D, Manson J, et al. Work characteristics and incidence of type 2 diabetes in women. Am J Epidemiol 2007, 165(2):175-183.
99. Spiegel K, Sheridan JF, Van CE Effect of sleep deprivation on response to immunization. JAMA 2002, 288(12):1471-1472.
100. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004, 43(4):678-683.
101. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009, 41(1):89-94.
102. Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med 2007, 8(6):668-680.
103. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 2006, 47(5):833-839.
104. Grossman E, Laudon M, Yalcin R, et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 2006, 119(10):898-902.
105. Scheer FA, Van Montfrans GA, van Someren EJ, et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004, 43(2):192-197.
106. Waterhouse J, Reilly T, Atkinson G, Edwards B Jet lag: trends and coping strategies. Lancet 2007, 369(9567):1117-1129.
107. Revell VL, Burgess H, Gazda C, et al. Advancing human circadian rhythms with afternoon melatonin and norming intermittent bright light. J Clin Endocrinol Metab 2006, 91(1):54-59.
108. Pandi-perumal SR, Trakht I, Spence D, et al. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. Nat Clin Pract Neurol 2008, 8:436-447.
109. Herxheimer A, Petrie K. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev 2002;(2):CD001520.
110. Barion A, Zee PC A clinical approach to circadian rhythm sleep disorders. Sleep Med 2007, 8(6):566-577.
111. Buysse DJ Diagnosis and assessment of sleep and circadian rhythm disorders. J Psychiatr Pract 2005, 11(2):102-115.
112. Ancoli-Israel S, Cole R, Alessi C, et al. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003, 26(3):342-392.
113. Cooke JR, Ancoli-Israel S Sleep and its disorders in older adults. Psychiatr Clin North Am 2006, 29(4):1077-1093.
114. Dijk DJ, Duffy JF, Czeisler CA Contribution of circadian physiology and sleep homeostasis to age-related changes in human sleep. Chronobiol Int 2000, 17(3):285-311.
115. Cajochen C, Munch M, Knoblauch V, et al. Age-related changes in the circadian and homeostatic regulation of human sleep. Chronobiol Int 2006, 23(1-2):461-474.
116. Garfinkel D, Laudon M, Nof D, Zisapel N Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995, 348(8974):541-544.
117. Koster-van Hoffen GC, Mirmiran M, Bos NP, et al. Effects of a novel melatonin analog on circadian rhythms of body temperature and activity in young, middle-aged, and old rats. Neurobiol Aging 1993, 14(6):565-569.
118. Dahlitz M, Alvarez B, Vignau J, et al. Delayed sleep phase syndrome response to melatonin. Lancet 1991, 337(8750):1121-1124.
119. Oldani A, Ferini-Strambi L, Zucconi M, et al. Melatonin and delayed sleep phase syndrome: ambulatory polygraphic evaluation. Neuroreport 1994, 6(1):132-134.
120. Nagtegaal J, Kerkhof G, Smits M, et al. Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. J Sleep Res 1998, 7(2):135-143.
121. Smits M, Nagtegaal E, van der Heijden J, et al. Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol 2001, 16(2):86-92.
122. Mundey K, Benloucif S, Harsanyi K, et al. Phase-dependant treatment of delayed sleep phase syndrome with melatonin. Sleep 2005, 28(10):1271-1278.
123. Wasdell M, Jan J, Bomben M, et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res 2008, 44(1):57-64.
124. van der Heijden BC, Smits M, van Someren EJ, et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry 2007, 46(2):233-241.
125. Skene DJ, Arendt J Circadian rhythm sleep disorders in the blind and their treatment with melatonin. Sleep Med 2007, 8(6):651-655.
126. Lewy AJ, Emens J, Lefler B, et al. Melatonin entrains free-running blind people according to a physiological dose-response curve. Chronobiol Int 2005, 22(6):1093-1106.
127. Wade A, Ford I, Crawford G, et al. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin 2007, 23(10):2597-2605.
128. Lemoine P, Nir T, Laudon M, Zisapel N Prolonged-release melatonin improves sleep quality and morning altertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007, 16(4):372-380.
129. Wade A, Downie S Prolonged-release melatonin for the treatment of insomnia in patients over 55 years. Expert Opin Investig Drugs 2008, 10:1567-1572.
130. Haimov I, Laudon M, Zisapel N, et al. Sleep disorders and melatonin rhythms in elderly people. BMJ 1994, 309(6948):167.
131. Lushington K, Dawson D, Kennaway DJ, Lack L The relationship between 6-sulphatoxymelatonin and polysomnographic sleep in good sleeping controls and wake maintenance insomniacs, aged 55-80 years. J Sleep Res 1999, 8:57-64.
132. Leger D, Laudon M, Zisapel N Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 2004, 116(2):91-95.
133. Vorkapic P, Waldhauser F, Bruckner R, et al. Serum melatonin levels: a new neurodiagnostic tool in pineal region tumors?. Neurosurgery 1987, 21(6):817-824.
134. Etzioni A, Luboshitzky R, Tiosano D, et al. Melatonin replacement corrects sleep disturbances in a child with pineal tumor. Neurology 1996, 46(1):261-263.
135. Kocher L, Brun J, Borson-Chazot F, et al. Increased REM sleep associated with melatonin deficiency after pinealectomy: a case study. Chronobiol Int 2006, 23(4):889-901.
136. Quera-Salva MA, Bensmail D, Hartley S, et al. Circadian rhythms in young adults following pinealectomy. Sleep 2008, 31:0157.
137. Ferrari EA, Arcaini A, Gornati R, et al. Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp Gerontol 2000, 35(9-10):1239-1250.
138. van Someren EJ, Hagebeuk EE, Lijzenga C, et al. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry 1996, 40(4):259-270.
139. Wahlund B Melatonin in psychiatric disorders -subtyping affective disorder. Biol Signals Recept 1999, 8(1-2):120-125.
140. Wahlund B, Grahn H, Saaf J, Wetterberg L Affective disorder subtyped by psychomotor symptoms, monoamine oxidase, melatonin and cortisol: identification of patients with latent bipolar disorder. Eur Arch Psychiatry Clin Neurosci 1998, 248(5):215-224.
141. Bylesjo I, Forsgren L, Wetterberg L Melatonin and epileptic seizures in patients with acute intermittent porphyria. Epileptic Disord 2000, 2(4):203-208.
142. Vogler B, Rapoport AM, Tepper SJ, et al. Role of melatonin in the pathophysiology of migraine: implications for treatment. CNS Drugs 2006, 20(5):343-350.
143. Peres MF, Masruha MR, Zukerman E, et al. Potential therapeutic use of melatonin in migraine and other headache disorders. Expert Opin Investig Drugs 2006, 15(4):367-375.
144. De Leersnyder H, de Blois MC, Bresson JL, et al. [Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome]. Rev Neurol (Paris) 2003, 159(11 Suppl.). 6S21-6S26.
145. Shamir E, Rotenberg V, Laudon M, et al. First-night effect of melatonin treatment in patients with chronic schizophrenia. J Clin Psychopharmacol 2000, 20(6):691-694.
146. Kemp S, Biswas R, Neumann V, et al. The value of melatonin for sleep disorders occuring post-head injury: a pilot RCT. Brain Inj 2004, 18(9):911-919.
147. Citera G, Arias M, Maldonado-Cocco J, et al. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol 2000, 19(1):9-13.
148. Kunz D, Bes F Exogenous melatonin in peridic limb movement disorder: an open clinical trial and a physothesis. Sleep 2001, 24(2):183-187.
149. Campos F, da Silva-Junior F, de Bruin V, de Bruin P Melatonin improves sleep in asthma: a randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2004, 170(9):947-951.
150. Dowling G, Mastick J, Colling E, et al. Melatonin for sleep disturbances in Parkinson's disease. Sleep Med 2005, 6(5):459-466.
151. Medeiros C, Carvalhedo de Bruin P, et al. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study. J Neurol 2007, 254(4):459-464.
152. Adi N, Mash DC, Ali Y, et al. Melatonin MT1 and MT2 receptor expression in Parkinson's disease. Med Sci Monit 2010, 16:BR61-7.
153. Aurora RN, Zak RS, Maganti RK, et al. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 2010, 6:85-95. Standards of Practice Committee, American Academy of Sleep MedicineAmerican Academy of Sleep Medicine.